Advanced company searchLink opens in new window

AWAKN BRISTOL LIMITED

Company number 10237533

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Sep 2024 GAZ2 Final Gazette dissolved following liquidation
21 Jun 2024 LIQ14 Return of final meeting in a creditors' voluntary winding up
10 Aug 2023 LIQ02 Statement of affairs
04 Aug 2023 NDISC Notice to Registrar of Companies of Notice of disclaimer
01 Aug 2023 AD01 Registered office address changed from 1 Regent Street Bristol BS8 4HW to 6th Floor 9 Appold Street London EC2A 2AP on 1 August 2023
01 Aug 2023 600 Appointment of a voluntary liquidator
01 Aug 2023 RESOLUTIONS Resolutions
  • LRESEX ‐ Extraordinary resolution to wind up on 2023-07-14
15 Jul 2023 MA Memorandum and Articles of Association
15 Jul 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
28 Jun 2023 TM01 Termination of appointment of James Collins as a director on 23 June 2023
19 May 2023 AP01 Appointment of Mr. Jonathan Held as a director on 17 May 2023
18 Apr 2023 TM01 Termination of appointment of Benjamin St John Sessa as a director on 27 March 2023
18 Apr 2023 PSC05 Change of details for Awakn Life Sciences, Inc. as a person with significant control on 27 March 2023
18 Apr 2023 PSC07 Cessation of Benjamin St John Sessa as a person with significant control on 27 March 2023
21 Mar 2023 AA Total exemption full accounts made up to 31 March 2022
27 Dec 2022 AA01 Previous accounting period shortened from 31 March 2022 to 30 March 2022
30 Jun 2022 CS01 Confirmation statement made on 17 June 2022 with updates
23 Jun 2022 AP01 Appointment of Mr James Collins as a director on 7 June 2022
22 Jun 2022 TM01 Termination of appointment of Katherine Butler as a director on 7 June 2022
10 Mar 2022 AP01 Appointment of Katherine Butler as a director on 4 March 2022
10 Mar 2022 TM01 Termination of appointment of Jonathan James Held as a director on 4 March 2022
22 Dec 2021 AA Total exemption full accounts made up to 31 March 2021
24 Jun 2021 CS01 Confirmation statement made on 17 June 2021 with updates
24 Jun 2021 PSC04 Change of details for Dr Benjamin St John Sessa as a person with significant control on 30 November 2020
24 Jun 2021 PSC05 Change of details for Awakn Life Sciences, Inc. as a person with significant control on 30 November 2020